Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age (about 8–13%). It is a cause of anovulatory infertility, hirsutism and long-term metabolic disease.
Diagnosis: Rotterdam criteria (2 of 3)
- Oligo- or anovulation (irregular or absent periods).
- Hyperandrogenism: clinical (hirsutism, acne, alopecia) or biochemical (raised testosterone, free androgen index).
- Polycystic ovaries on ultrasound: ≥ 20 follicles in one ovary or ovarian volume ≥ 10 ml (or raised AMH).
Other causes must be excluded: thyroid disease, hyperprolactinaemia, non-classic congenital adrenal hyperplasia (17-OH progesterone), Cushing syndrome, androgen-secreting tumours (very high testosterone, rapid virilisation).
Pathophysiology
- Insulin resistance with compensatory hyperinsulinaemia (in most, worse with obesity) stimulates ovarian androgen production and lowers SHBG.
- Raised LH pulse frequency, LH:FSH ratio often > 2, drives theca cell androgens.
- Follicles start growing but arrest: anovulation and the polycystic appearance.
Management
- Weight loss (5–10%) and exercise: improves cycles, fertility and metabolic risk.
- Irregular periods: combined oral contraceptive or cyclical progestogens (at least 4 withdrawal bleeds a year protect the endometrium), or the levonorgestrel IUS.
- Hirsutism: combined pill (with cyproterone acetate or drospirenone), spironolactone with contraception, cosmetic measures, eflornithine cream.
- Infertility: letrozole first line for ovulation induction (clomiphene an alternative), metformin as an adjunct, then gonadotrophins (risk of OHSS), laparoscopic ovarian drilling, IVF.
- Screen for diabetes (OGTT or HbA1c), lipids, BP, mood.
PCOS is diagnosed by any two of: irregular ovulation, high androgens, polycystic ovaries, once other causes are excluded.